Apidra 3.49 mg/mL (equivalent to 100 Units/mL)
Country: Philippines
Language: English
Source: FDA (Food And Drug Administration)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Insulin Glulisine
Available from:
Sanofi-Aventis Philippines, Inc.; Distributor: Sanofi-Aventis Philippines, Inc.
INN (International Name):
Insulin Glulisine
Dosage:
3.49 mg/mL (equivalent to 100 Units/mL)
Pharmaceutical form:
Solution for Subcutaneous/Continuous SC Pump Infusion/ Intravenous Injection
Units in package:
10 mL Type I Colorless Glass Vial (Box of 1's), Type I colourless glass vial in 10mL (box of 1's)
Manufactured by:
Sanofi-Aventis Deutschland GmbH, Germany
Product summary:
Solution for Subcutaneous/Continuous SC Pump Infusion/ Intravenous Injection
Authorization date:
2021-02-26
